Table 3 Mean values of thrombocytes, leucocytes, GOT, GPT, TSH and albumin at the following time points: before cCRT; before Durvalumab; at 3-, 6-, 9- and 12-month follow-up. We also calculated weight changes as a percentage of baseline at each time point
Reference value | Baseline | Start Durvalumab | 3-month follow-up | 6-month follow-up | 9-month follow-up | 12-month follow-up | |
|---|---|---|---|---|---|---|---|
Thrombocytes [G/l] | 176–391 | 286.91 | 247.68 | 254.41 | 267.00 | 252.70 | 279.63 |
Leukocytes [G/l] | 4–10.4 | 7.70 | 5.83 | 6.35 | 6.81 | 6.81 | 7.30 |
GOT [U/l] | > 49 | 25.82 | 26.59 | 27.95 | 27.79 | 27.16 | 30.17 |
GPT [U/l] | > 49 | 27.64 | 28.64 | 28.50 | 29.84 | 31.26 | 36.56 |
TSH [μU/ml] | 0.27–4.2 | 1.35 | 1.34 | 1.64 | 3.09 | 1.86 | 2.05 |
Albumin [g/dl] | 3,5 - 5,2 | 4.01 | 4.09 | 4.10 | 4.25 | 4.18 | 4.20 |
Weight change [%] | – | – | - 2 | 0 | + 2 | + 4 | + 3 |